D
Denali Therapeutics
DNLI · NASDAQ · Healthcare
$24.83
+$0.10 (+0.40%) today
Loading live data...
Market Cap
$3.94B
24h Volume
$43.4M
P/E Ratio
-7.6
52w High
$27.21
52w Low
$12.75
Est. AI Revenue
15%
Loading chart data...
7-Day Sparkline (Static)
About Denali Therapeutics
Biotechnology company using AI/ML for drug discovery targeting neurodegenerative diseases including Alzheimer's and Parkinson's.
CEO: Ryan Watts
Founded: 2013
HQ: South San Francisco, California
Employees: 507
Performance
24 Hours+0.40%
7 Days+7.86%
30 Days-8.75%
1 Year+77.87%